Drug
Silevertinib IN Combination With Temozolomide
Silevertinib IN Combination With Temozolomide: highest development phase Phase 2, developed by Black Diamond Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Black Diamond Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| silevertinib in combination with temozolomide NCT07326566 | Phase 2 | Glioblastoma (GBM) |
Latest
No recent events.
Follow Silevertinib IN Combination With Temozolomide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.